<- Go Home

ArQule, Inc.

ArQule, Inc., a biopharmaceutical company, researches and develops therapeutics for the treatment of cancer and rare diseases in the United States.

Market Cap

$2.4B

Volume

1.9M

Cash and Equivalents

$42.2M

EBITDA

-$38.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$26.2M

Profit Margin

-547.98%

52 Week High

$20.45

52 Week Low

$3.15

Dividend

N/A

Price / Book Value

15.76

Price / Earnings

-58.12

Price / Tangible Book Value

15.76

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$38.2M

Return on Equity

-32.12%

Return on Assets

-16.32

Cash and Short Term Investments

$125.2M

Debt

$17.3M

Equity

$153.1M

Revenue

$4.8M

Unlevered FCF

-$16.3M

Sector

Biotechnology

Category

N/A

Company Stock Pitches